Europe Antinuclear Antibody Test Market Size & Outlook
Europe antinuclear antibody test market, 2018-2030 (US$M)
Related Markets
Europe antinuclear antibody test market highlights
- The Europe antinuclear antibody test market generated a revenue of USD 483.5 million in 2023.
- The market is expected to grow at a CAGR of 13% from 2024 to 2030.
- In terms of segment, reagents & assay kits was the largest revenue generating product in 2023.
- Reagents & Assay Kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 483.5 million |
| Market revenue in 2030 | USD 1,135.6 million |
| Growth rate | 13% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & assay kits |
| Fastest growing segment | Reagents & Assay Kits |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Assay Kits, Systems, Software & Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Immunodiagnostic Systems, Inova Diagnostics, Trinity Biotech PLC ADR, Sebia, Antibodies, Erba Diagnostics, Revvity Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 31.0% of the global antinuclear antibody test market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 710.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antinuclear Antibody Test Market Scope
Antinuclear Antibody Test Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe antinuclear antibody test market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antinuclear antibody test market will help companies and investors design strategic landscapes.
Reagents & assay kits was the largest segment with a revenue share of 47.24% in 2023. Horizon Databook has segmented the Europe antinuclear antibody test market based on reagents & assay kits, systems, software & services covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Antinuclear Antibody Test Product Outlook (Revenue, USD Million, 2018-2030)
- Reagents & Assay Kits
- Systems
- Software & Services
- Europe Antinuclear Antibody Test Technique Outlook (Revenue, USD Million, 2018-2030)
- ELISA
- Immunofluorescence Assay
- Multiplex Assay
- Europe Antinuclear Antibody Test Application Outlook (Revenue, USD Million, 2018-2030)
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Sjogren’s Syndrome
- Scleroderma
- Other Diseases
- Europe Antinuclear Antibody Test End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinical Laboratories
- Physician Office Laboratories
- Other End-uses
Reasons to subscribe to Europe antinuclear antibody test market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe antinuclear antibody test market databook
-
Our clientele includes a mix of antinuclear antibody test market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe antinuclear antibody test market, including forecasts for subscribers. This continent databook contains high-level insights into Europe antinuclear antibody test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe antinuclear antibody ana test market size, by country, 2018-2030 (US$M)
Europe Antinuclear Antibody Test Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
